AKT1 and colorectal carcinoma: Ruthenium(II)-cyclopentadienyl-derived complexes were reported to induce apoptosis in CRC RKO and SW480 cell lines via inhibition of the MEK/ERK and PI3K/Akt signaling pathways [20].